3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
111
Triple Negative Breast Neoplasms
25
Lung Neoplasms
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Colonic Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Liver Neoplasms
3
Kidney Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Multiple Myeloma
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Laryngeal Neoplasms
2
Gastrointestinal Neoplasms
2
Fatigue
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Bile Duct Neoplasms
2
Interventions
Control Groups
3
Anesthetics, Local
3
Sodium Chloride
2
Magnesium Sulfate
2
Levobupivacaine
2
Ketamine
2
Dental Occlusion
2
Anesthesia, Local
2
Analgesics, Opioid
2
Transdermal Patch
1
Tramadol
1
Surveys and Questionnaires
1
Saline Solution
1
S-Adenosylmethionine
1
Ropivacaine
1
Propofol
1
Pregabalin
1
Nerve Block
1
Musculoskeletal Manipulations
1
Lidocaine
1
Ibuprofen
1
High-Energy Shock Waves
1
Exercise Therapy
1
Exercise
1
Drug Therapy
1
Codeine
1
Capsaicin
1
Bupivacaine
1
Breathing Exercises
1
Botulinum Toxins, Type A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Drug Therapy
×
Breast
×
Clear all
NCT07152938
2025-09-15
AVR-CHEMO
Arab American University (Palestine)
Phase NA
Completed
150 enrolled